diabetes – AJKD Blog

#NephMadness 2020: Thinking Outside The Paint – SGLT2 Inhibitors for Patients Without Diabetes Mellitus?

April 29, 2020 // 0 Comments

Brendon Neuen @brendonneuen Brendon Neuen is an academic nephrology registrar at Royal North Shore Hospital and an NHMRC Postgraduate Scholar at The George Institute in [...]

#NephMadness 2020: SGLT2i Region

March 13, 2020 // 2 Comments

Submit your picks! | NephMadness 2020 | #NephMadness | #SGLT2iRegion Selection Committee Member: Meg Jardine @jardine_meg Meg Jardine is Program Head of Innovation & [...]

#NephMadness 2020: Hyperkalemia Region

March 13, 2020 // 0 Comments

Submit your picks! | NephMadness 2020 | #NephMadness | #HyperKRegion Selection Committee Member: Deborah Clegg Deborah Clegg is Associate Dean of Research in the College [...]

Sweet Pee: Do SGLT2 Inhibitors Prevent and/or Slow the Progression of Diabetic Kidney Disease?

August 15, 2018 // 1 Comment

During NephMadness 2017, the newcomer ‘SGLT2 inhibitors’ team for the Diabetic Nephropathy region surprised the competition and made it all the way to the Filtered Four [...]

Creatinine Linearity – Connecting the Dots Has Never Been So Complicated

December 8, 2017 // 0 Comments

Prediction. My least favorite part of the chronic kidney disease (CKD) clinic visit. “No crystal ball.” “I’m not in a position to guess.” “Only God knows the [...]

#NephMadness 2017: The Changing Nature of Diabetic Kidney Disease

March 28, 2017 // 0 Comments

NephMadness 2017 | @NephMadness | #NephMadness or #DNRegion Raymond C. Harris Dr. Harris, MD, is Director of the Division of Nephrology at Vanderbilt University [...]

#NephMadness 2017: The Year of the Gs – GLP-1 Receptor Agonists and Gonzaga

March 21, 2017 // 1 Comment

Submit your picks! | NephMadness 2017 | #NephMadness or #DNRegion Katherine R. Tuttle Dr. Tuttle, MD, is Executive Director for Research at Providence Health Care in [...]

#KidneyWk 2016: State of the Art Lectures

November 22, 2016 // 0 Comments

One of the major highlights of KidneyWk 2016 is the State of the Art Lectures, which are presented daily in the plenary session by a renowned scientist. These are topics of [...]

#KidneyWk 2015: Not Just VEGF: Diabetes and the Endothelium

November 10, 2015 // 0 Comments

Diabetes and Diabetic Nephropathy (DN) were appropriately prominent topics at this year’s meeting. Thursday’s afternoon session, “Glomerular Endothelial Cell Injury [...]

Somatomedins and the Kidneys

September 18, 2014 // 0 Comments

Insulin-like growth factors (IGF) are a group of peptides that include insulin and relaxins with a common structural feature of three disulfide bonds linking a variable and a [...]